INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of INDO US BIOTECH ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of INDO US BIOTECH Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹273.5 Cr | 16.7% | -3.5% | -40.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,796.5 Cr | -1.4% | -9.1% | -27% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,106.4 Cr | 4.4% | -5.8% | 10.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,895.5 Cr | 0.6% | -8.5% | -21.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,102.7 Cr | -6.5% | -14.2% | -26.4% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹510.5 Cr | 5.2% | 4.4% | 33.4% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 16.7% |
-3.5% |
-40.7% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses